Table 1.
Characteristics of the tested IGF-I assays as provided by the manufacturers. The limit of quantification (LOQ) is the lowest amount of IGF-I that can be accurately quantified with an allowable error of ≤20%. The limit of detection (LOD) is the IGF-I concentration corresponding to the 95th percentile value from a number of determinations of IGF-I concentration in free serum samples.
| Name of the assay | Manufacturer | Automated | Tracer | International standard against which the assay is calibrated | Intra-assay CV | Inter-assay CV | LOQ or LOD in ng/mL | Highest measurable value without dilution (ng/mL) | Reference adult population recruited by the manufacturer |
|---|---|---|---|---|---|---|---|---|---|
| Elecsys® IGF-1 | Roche Diagnostics | Yes | Ruthenium | WHO international standard 02/254 | Human samples between 1.4 and 3.5% | Human samples between 2.5 and 4.6% | LoQ 15 ng/mL LoD 7 ng/mL |
1600 ng/mL | 3652 men between 3 months and 80 years 3046 women between 3 months and 80 years |
| IMMULITE® 20000 IGF-I | Siemens | Yes | Phosphatase alcaline | WHO international standard 02/254 | Human samples between 2.4 and 6.3% | Human samples between 3 and 7.6% | LoQ 24.9 ng/mL LoD 13.3 ng/mL |
90,000 ng/mL | 701 pediatric and 1104 adult samples |
This work is licensed under a